GEORGE CHOLANKERIL to Antiviral Agents
This is a "connection" page, showing publications GEORGE CHOLANKERIL has written about Antiviral Agents.
Connection Strength
2.502
-
Recent advances in liver transplantation with HCV seropositive donors. F1000Res. 2019; 8.
Score: 0.412
-
Direct-Acting Antiviral Therapy and Improvement in Graft Survival of Hepatitis C Liver Transplant Recipients. Transplantation. 2017 12; 101(12):e349.
Score: 0.356
-
Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct-Acting Antiviral Agents. Clin Gastroenterol Hepatol. 2018 03; 16(3):452-453.
Score: 0.350
-
Rates of liver retransplantation in the United States are declining in the era of direct-acting antiviral agents. J Viral Hepat. 2017 12; 24(12):1194-1195.
Score: 0.349
-
Improved Survival After Liver Transplantation for Patients With Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus Coinfection in the Integrase Strand Transfer Inhibitor and Direct-Acting Antiviral Eras. Clin Infect Dis. 2023 02 18; 76(4):592-599.
Score: 0.128
-
Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era. Clin Gastroenterol Hepatol. 2023 08; 21(9):2288-2297.e4.
Score: 0.126
-
Comparable Survival for Hepatitis C-Related Hepatocellular Carcinoma After Liver Transplantation Irrespective of Viremic Status. Clin Gastroenterol Hepatol. 2023 05; 21(5):1362-1364.e1.
Score: 0.120
-
Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients. Hepatology. 2018 08; 68(2):792-793.
Score: 0.093
-
Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates. World J Gastroenterol. 2018 Jan 21; 24(3):315-322.
Score: 0.090
-
Optimal timing for hepatitis C antiviral therapy in the peritransplant period? Hepatology. 2017 09; 66(3):1004.
Score: 0.087
-
Treatment of patients waitlisted for liver transplant with all-oral direct-acting antivirals is a cost-effective treatment strategy in the United States. Hepatology. 2017 07; 66(1):46-56.
Score: 0.086
-
The Role of e-Health in Optimizing Task-Shifting in the Delivery of Antiviral Therapy for Chronic Hepatitis C. Telemed J E Health. 2017 10; 23(10):870-873.
Score: 0.085
-
Indications for antiviral therapy for chronic hepatitis B in pregnant mothers. BMJ Case Rep. 2016 Nov 15; 2016.
Score: 0.083
-
Changing trends in aetiology-based hospitalizations with end-stage liver disease in the United States from 2016 to 2019. Liver Int. 2022 11; 42(11):2390-2395.
Score: 0.031
-
Trends in the Prevalence of Hepatitis C Virus Infection based on the Insurance Status in the United States from 2013 to 2018. Liver Int. 2022 02; 42(2):340-349.
Score: 0.029
-
Trends in mortality in hepatitis C infection and alcoholic liver disease based on drug overdose in the United States. J Viral Hepat. 2021 02; 28(2):436-439.
Score: 0.027
-
Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017. Gastroenterology. 2019 10; 157(4):1055-1066.e11.
Score: 0.025
-
Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016. Gastroenterology. 2018 10; 155(4):1154-1163.e3.
Score: 0.023